Lung cancer screening for veterans in community care: how to improve care and follow-up
Official title: Lung Cancer Screening for Veterans Enrolled in Community Care: Modifiable Mechanisms to Improve Patient-Centered Outcomes
Funded at Portland VA Medical Center · NIH-11373814 · Data updated 2026-11-12
This project looks at how to make lung cancer screening better for veterans who get care outside VA facilities, focusing on keeping people up to date with follow-up and improving communication.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Portland VA Medical Center NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| NIH project number | 5I01HX003725-03 |
| Project ID | NIH-11373814 on NIH RePORTER |
Who could benefit from this research
✓Could help
Veterans and non-Veterans eligible for lung cancer screening who may receive care in VA and non-VA settings.
✕Less likely to help
People not eligible for LDCT screening or those not engaged with the lung cancer screening process may see limited direct benefit.
What this research studies
Veterans often get lung cancer screening (LDCT) in non-VA settings, which can lead to gaps in care and follow-up. The project will analyze data from VA and non-VA facilities to identify problems and modifiable steps that could improve adherence and outcomes. A systems dynamics model and qualitative analysis will help pinpoint what changes in processes and communication could most boost patient-centered results. The goal is to make screening safer and more effective for millions of current and former service members, regardless of where they receive care.
Why it matters
Potential benefit: If successful, the project could lead to clearer follow-up, better adherence to screening schedules, and fewer harms from missed or delayed results for veterans and others.
How similar studies have gone: This approach aims to be the first large-scale evaluation of LCS processes across VA and non-VA settings with a focus on patient-centered outcomes.
Where this research is happening
-
Portland VA Medical Center
Portland, United States Active
Researchers
- Principal investigator: Slatore, Christopher G. — Portland VA Medical Center
- Study coordinator: Slatore, Christopher G.
Related research
Other NIH-funded projects on the same topics.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Population health approach to boost lung cancer screening at community clinics
A large Utah project aims to help community clinics reach more eligible adults to get low-dose CT lung cancer screening.
-
Group-based tobacco treatment for older adults after lung cancer screening
A study tests a group-based tobacco cessation program for older adults who are getting lung cancer screening to help them quit smoking.
-
Personalized Lung Cancer Screening for Veterans
Aimed at improving who gets screened and how lung cancer is diagnosed among Veterans using personalized tools.
-
Proteogenomic framework to improve lung cancer screening with biomarkers
A biomarker-based approach aims to refine LDCT lung cancer screening so more cancers are caught early while reducing unnecessary procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.